Kronos Worldwide Inc. (NYSE:KRO) traded up 1.4% on Friday . The company traded as high as $5.97 and last traded at $5.92, with a volume of 124,953 shares changing hands. The stock had previously closed at $5.84.

Separately, Zacks Investment Research downgraded shares of Kronos Worldwide from a “hold” rating to a “sell” rating in a research report on Wednesday.

The stock’s 50-day moving average price is $5.59 and its 200-day moving average price is $5.59. The stock’s market capitalization is $692.96 million.

Kronos Worldwide (NYSE:KRO) last posted its quarterly earnings data on Friday, May 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.13) by $0.10. During the same period in the prior year, the company posted $0.16 earnings per share. The firm had revenue of $318.40 million for the quarter, compared to the consensus estimate of $308.50 million. Kronos Worldwide’s quarterly revenue was down 12.8% on a year-over-year basis. On average, equities research analysts predict that Kronos Worldwide Inc. will post $0.03 earnings per share for the current fiscal year.

A hedge fund recently raised its stake in Kronos Worldwide stock. Morgan Stanley boosted its stake in Kronos Worldwide Inc. (NYSE:KRO) by 64.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 267,530 shares of the company’s stock after buying an additional 105,140 shares during the period. Morgan Stanley owned approximately 0.23% of Kronos Worldwide worth $1,509,000 at the end of the most recent quarter.

Kronos Worldwide, Inc is a producer and marketer of titanium dioxide (TiO2) pigments, a base industrial product that is used in a range of applications. The Company, along with its distributors and agents, sells and provides technical services for its products in approximately 100 countries with sales in Europe and North America.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.